Jorge Barbazan

Jorge Barbazan, PhD, currently serves as AECC Investigador and Senior Researcher at the Health Research Institute of Santiago de Compostela since October 2020. In April 2024, Jorge co-founded Batea Oncology, taking on the role of Chief Scientific Officer. Previously, from May 2021 to March 2024, Jorge worked as an Associate Scientist at NASASBIOTECH SL, and from February 2015 to October 2020, held the position of Senior Researcher and Project Manager at Institut Curie, overseeing a multidisciplinary international team and managing research strategies. Jorge's earlier experience includes postdoctoral roles at Oncomet lab. Fundación Ramón Domiínguez, and a PhD focused on translational oncology research. Jorge holds a Licenciado en Biologia, Biologia Molecular y Biotecnologia from Universidad de Santiago de Compostela and briefly attended the Technical University of Munich in 2011.